论文信息 - Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer - 字舞流文

Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer

J. Tabernero | J. Trojan | H. Oettle | D. Melisi | S. Estrem | G. Deplanque | D. Pezet | R. García-Carbonero | A. Cleverly | T. Macarulla | I. Gueorguieva | K. Benhadji | M. Lahn | M. Kozloff | Claire L Smith | M. Fuchs | A. Blunt